Table 4.
Adverse reactions to floxuridine n (%)
| Treatment group (toxicity) |
NCI-CTC grade |
|
| 1-2 | 3-4 | |
| Fever | 2 (5.9) | 0 (0) |
| Nausea/vomiting | 0 (0) | 0 (0) |
| Gastric or duodenal ulcer | 3 (8.8) | 4 (11.8) |
| Mucositis | 4 (11.8) | 3 (8.8) |
| Diarrhea | 4 (11.8) | 3 (8.8) |
| Leukopenia | 2 (5.9) | 1 (2.9) |
| Thrombocytopenia | 2 (5.9) | 1 (2.9) |
| Bilirubin elevation | 4 (11.8) | 1 (2.9) |
| AST/ALT elevation | 5 (14.7) | 1 (2.9) |
| BUN/Cr elevation | 0 (0) | 1 (2.9) |
| Catheter infection | 1 (2.9) | |
| Total | 19 | 9 |
NCI-CTC: National Cancer Institute Common Toxicity Criteria; AST: Aspartate transaminase; ALT: Alanine transaminase; BUN: Blood urea nitrogen; Cr: Creatinine.